Nov 3, 8:07 AM ET
Henry Schein reported third-quarter 2026 results for the quarter ended September 26, 2026, with net sales of $3.5 billion, up 4.0%, and GAAP diluted EPS of $1.06, up 26.2% from the prior year. The company raised its 2026 non-GAAP diluted EPS guidance to $5.50 to $5.56 from $5.29 to $5.39, and the Q3 results include a $0.19 per share net benefit from tariff refunds, which management says will not recur at that level for the rest of 2026.
- Q3 2026 non-GAAP diluted EPS was $1.56, up 13.0%; excluding tariff refunds and prior-year remeasurement gains, growth was 19.1%
- Full-year 2026 non-GAAP diluted EPS guidance raised to $5.50 to $5.56 from $5.29 to $5.39
- Adjusted EBITDA growth guidance raised to high-single-digits from mid to high-single-digits
- Q3 U.S. dental merchandise sales rose 8.6%; the company repurchased $125 million of stock in the quarter and had about $330 million authorized remaining
Read the filing on SEC.gov ↗
Oct 8, 7:00 AM ET
Henry Schein said former ITT CFO Emmanuel Caprais will become its Senior Vice President and Chief Financial Officer effective November 4, 2026, succeeding Ronald N. South, who moves to a Senior Advisor role on that date. Mr. Caprais joins as Senior Financial Advisor on October 12, 2026, and Mr. South remains CFO through November 3, 2026, including the third quarter earnings process. The filing describes a planned, structured handover of the finance chief role rather than a financial result.
- Emmanuel Caprais, 51, most recently served as CFO of ITT Inc. from 2020 to May 2026; he will report to CEO Frederick M. Lowery
- Offer Letter sets a $750,000 base salary, a $750,000 target annual bonus, and a $25,000 sign-on bonus
- Expected 2027 long-term incentive award has an estimated grant date fair value of $2,500,000, plus a $250,000 one-time sign-on equity award granted in December 2026
- Ronald N. South has served at Henry Schein for 18 years and as CFO for the past four years
Read the filing on SEC.gov ↗
Sep 22, 6:35 AM ET
Henry Schein amended and restated its existing $1 billion revolving credit agreement on September 21, 2026, increasing commitments to $1.25 billion and extending the termination date to September 19, 2031. The company plans to use the facility for working capital, general corporate purposes, capital expenditures, stock repurchases, debt refinancing and potential acquisitions.
- Revolving commitments increased from $1 billion to $1.25 billion
- Termination date extended to September 19, 2031
- Agreement signed September 21, 2026, amending a credit agreement dated June 6, 2025
- JPMorgan Chase Bank, N.A. is administrative agent; the filing lists several co-agents and lenders
Read the filing on SEC.gov ↗
Aug 4, 6:13 AM ET
Henry Schein reported second-quarter 2026 net sales of $3.5 billion, up 6.7% from a year earlier, and non-GAAP diluted EPS of $1.27 versus $1.10. It raised its full-year 2026 non-GAAP diluted EPS guidance to $5.29 to $5.39 from $5.23 to $5.37, and its sales growth guidance to 4.5% to 5.5% from 3% to 5%. For shareholders, both headline profit and guidance moved higher.
- Q2 2026 net sales were $3.5 billion, up 6.7%, including 4.6% internal sales growth
- Q2 2026 GAAP diluted EPS was $0.82 versus $0.70; non-GAAP diluted EPS was $1.27 versus $1.10
- 2026 non-GAAP diluted EPS guidance raised to $5.29 to $5.39 from $5.23 to $5.37; sales growth guidance raised to 4.5% to 5.5% from 3% to 5%
- Repurchased $200 million of common stock in Q2; $455 million remained authorized at quarter end
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
